3 5
Phytosterol biosynthesis -parallel branches for stigmasterol and campesterol 2 8 9
From 24-methylenelophenol onwards, the pathway bifurcates via two separate 2 9 0 branches, eventually resulting in either 24-ethylsterols (β-sitosterol and stigmasterol) or 24-2 9 1 methylsterols (campesterol) as end-products, respectively. Campesterol can subsequently be 2 9 2 used as a precursor for brassinosteroid biosynthesis. 2 9 3
The 24-ethylsterol branch pathway begins with a second methylation of the C-24 2 9 4 position of 24-methylenelophenol by the enzymes C-24 sterol methyltransferase 2/cotyledon 2 9 5 vascular pattern 1 (SMT2/CVP1) and C-24 sterol methyltransferase 3 (SMT3), which results in 2 9 6 24-ethylidenelophenol (Bouvier-Nave et al., 1998; Carland et al., 2010) . Like with SMT1, the 2 9 7 reaction catalyzed by SMT2/CVP1 is an important regulatory step in sterol biosynthesis, since it 2 9 8 determines the ratio of 24-methyl-and 24-ethylsterols, which affects several developmental 2 9 9 processes in plants (Bouvier-Nave et al., 1997; Carland et al., 2002; Schaeffer et al., 2001) . 3 0 0
Interestingly, it is thought that SMT2/CVP1 is also able to catalyze the primary C-24 methylation 3 0 1 catalyzed by SMT1, albeit to a lesser extend (Schaeffer et al., 2001) . A following double 3 0 2 demethylation of 24-ethylidenelophenol by sterol-4α-methyl oxidase 2 (SMO2) results in the 3 0 3 formation of Δ 7 -avenasterol (Darnet and Rahier, 2004) , which is subsequently converted to 5-3 0 4 dehydroavenasterol by the Δ 7 -sterol-C5-desaturase DWARF7/STEROL1 (DWF7/STE1) (Choe 3 0 5 et al., 1999b; Gachotte et al., 1996) . Next, the sterol Δ 7 -reductase DWARF5 (DWF5) converts 3 0 6 1 6 this 5-dehydroavenasterol into isofucosterol (Choe et al., 2000) . Finally, a C-24 reduction of 3 0 7 isofucosterol by the Δ 24 -sterol-Δ 24 -reductase DIMINUTO/DWARF1 (DIM/DWF1) leads to the 3 0 8 generation of β -sitosterol (Choe et al., 1999a) , which can then undergo a further C-22 3 0 9
desaturation by the C-22 sterol desaturase CYP710A1, resulting in the end-product of this 3 1 0 pathway: stigmasterol (Morikawa et al., 2006) . However, not many details are known about this 3 1 1 desaturation reaction in higher plants. Interestingly, in Arabidopsis, a second CYP710 enzyme 3 1 2 (CYP710A2) is also able to produce stigmasterol from β -sitosterol, and can also produce 3 1 3 brassicasterol from 24-epi-campesterol (Benveniste, 2002; Morikawa et al., 2006) . 3 1 4
The 24-methylsterol branch pathway starting from 24-methylenelophenol that eventually 3 1 5 leads to the production of campesterol is similar to the first one and mostly uses the same 3 1 6 enzymes. However, instead of first being methylated at the C-24 position by SMT2/CVP1 and 3 1 7 SMT3 during the first step of this branched pathway, 24-methylenelophenol is directly 3 1 8 demethylated by SMO2. This causes 24-methylenelophenol to be converted to episterol (Darnet 3 1 9
and Rahier, 2004). The rest of the pathway consists of the same steps as the first branched 3 2 0 pathway. First STE1 causes a desaturation of the C-5 position of episterol, which results in 5-3 2 1 dehydroepisterol. This is followed by a reduction of its C-7 position by DWF5, leading to 24-3 2 2 methylenecholesterol (Choe et al., 2000) . Finally, a reduction of the C-24 double bond of 24-3 2 3 methylenecholesterol by DIM/DWF1 yields the end-product of this pathway: campesterol. 3 2 4
Besides its function as a structural phytosterol in membranes, campesterol also acts as a 3 2 5 precursor for the brassinosteroid biosynthesis pathway (Choe et al., 1999a; Clouse, 2011) . For 3 2 6 details about brassinosteroid biosynthesis, we refer to dedicated reviews (Choe et al., 1999a; 3 2 7 Clouse, 2011). 3 2 8
The smt2/cvp1 mutant has increased campesterol levels and reduced β -sitosterol levels, 3 2 9 and is characterized by moderate developmental defects, such as disturbed venation patterns in 3 3 0 its cotyledons, serrated floral organs and a reduced stature (Carland et al., 2010; Carland et al., 3 3 1 1 7 2002). Unlike the early sterol biosynthesis mutants smt1, hyd1 and fk, more downstream sterol 3 3 2 biosynthesis mutants such as smt2/cvp1, dim/dwf1, dwf5 and dwf7/ste1 show no defects in 3 3 3 embryogenesis. The smt2/cvp1 mutant is smaller than the wild type, but it doesn't demonstrate 3 3 4 extreme dwarfism (Carland et al., 2002) . Although dim/dwf1, dwf5 and dwf7/ste1 affect 3 3 5 successive steps in the conversion of episterol to campesterol, and Δ 7 -avenasterol to β -3 3 6 sitosterol (Choe et al., 1999a; Choe et al., 1999b; Clouse, 2002) , the phenotypes of these 3 3 7 mutants resemble those of brassinosteroid-deficient mutants, reflecting the importance of 3 3 8 campesterol as a precursor of the most biologically active brassinosteroid, brassinolide. 3 3 9
However, while these mutants are significantly smaller than wild-type plants, they don't display 3 4 0 the extreme dwarfism that is typical of BR biosynthesis mutants. Furthermore, the sterol profile 3 4 1 of these mutants is vastly disturbed, with dwf7/ste1 being almost completely devoid of 3 4 2 campesterol (Choe et al., 1999b; Choe et al., 2000) . These macroscopic phenotypes can be 3 4 3 partially rescued by external application of BRs (Choe et al., 1999a; Choe et al., 1999b; Choe et 3 4 4 al., 2000; Klahre et al., 1998; Schaller, 2003) , demonstrating that they are largely caused by an 3 4 5 impairment in downstream BR synthesis, rather than a direct effect of campesterol deficiency. 3 4 6
However, since DIM/DWF1, DWF5 and DWF7/STE1 also catalyze the conversion steps of Δ 7 -3 4 7 avenasterol to β -sitosterol ( Fig. 2) , their respective mutants are not only deficient in 3 4 8 campesterol, but also in β -sitosterol and stigmasterol, suggesting that the resulting defects in 3 4 9 membrane integrity are at least partially responsible for the observed phenotypes of these 3 5 0 mutants. This is presumably the case for the observed fertility defects, since BR application 3 5 1 does not restore fertility in these mutants, suggesting that phytosterols play an important role 3 5 2 during the plant reproduction that is independent from BRs (Schaller, 2004). 3 5 3 Furthermore, unlike dim/dwf1, dwf5 and dwf7/ste1, the phenotypes of smt2/cvp1 and the 3 5 4 early sterol biosynthesis mutants smt1, cpi, fk and hyd1 cannot be rescued by BR treatment 3 5 5 (Carland et al., 2002; Diener et al., 2000; Schrick et al., 2000) . Since these phenotypes are 3 5 6 1 8 independent from the downstream BR pathway, it is possible that early synthesized sterols 3 5 7 (sterol biosynthesis intermediates) can act as signaling molecules themselves, similar to what 3 5 8 has been shown for cholesterol in animals (Edwards and Ericsson, 1999; Farese and Herz, 3 5 9 1998; Vriet et al., 2013) . For example, accumulation of the sterol biosynthesis intermediate 4-3 6 0 carboxy-4-methyl-24-methylenecycloartanol (CMMC), which accumulated in a mutant defective 3 6 1 in tethering the sterol C4-demethylation complex, interferes with auxin transport (Edwards and 3 6 2 Ericsson, 1999; Farese and Herz, 1998; Vriet et al., 2013) . Also of note is that the sterol 3 6 3 biosynthesis pathways are relatively conserved between Eukaryotes, with diatoms and yeast 3 6 4 using mostly similar or identical enzymes as the higher plants, albeit sometimes in a different 3 6 5 order, which explains the difference in end products obtained (e.g. ergosterol in yeast and 3 6 6 brassicasterol/campesterol in diatoms) (Fabris et al., 2014) . Overall, these mutants of early and 3 6 7 late steps of the sterol biosynthesis pathway have been excellent tools in aiding our 3 6 8 understanding of plant sterol biosynthesis and the role of sterols in plant growth and 3 6 9 development. 3 7 0 3 7 1
Cholesterol biosynthesis in plants
The major sterols in plants are β -sitosterol, campesterol and stigmasterol, but many 3 7 3 plants also produce cholesterol to some degree (Behrman and Gopalan, 2005) . While the 3 7 4 cholesterol levels in plants are usually low (100 -1000 times lower compared to animals), 3 7 5 cholesterol makes up a significant portion of the sterol content in some plant species (e.g. more 3 7 6 than 10% in Solanaceae) (Sonawane et al., 2016) . Furthermore, it has been shown to serve Cholesterol is the major sterol in animals, in which the cholesterol biosynthesis pathway 3 8 2 has been extensively studied and characterized (Nes, 2011) , while cholesterol biosynthesis in 3 8 3 plants is still not fully understood. Recently, several genes and enzymes involved in cholesterol 3 8 4 biosynthesis in tomato plants were identified by analyzing transcript and protein co-expression 3 8 5 data, as well as a combination of functional assays (Sonawane et al., 2016) . These data 3 8 6 demonstrated the involvement of 12 enzymes in the tomato cholesterol biosynthesis pathway, of 3 8 7
which several also function in the phytosterol biosynthesis pathway to catalyze highly related 3 8 8 enzymatic conversions. Furthermore, the other enzymes that are specific for the cholesterol 3 8 9 biosynthesis pathway seem to have evolved through gene duplication and divergence from 3 9 0 phytosterol biosynthetic enzymes (Sonawane et al., 2016) . Unlike animals, cholesterol 3 9 1 biosynthesis in plants does not seem to start from 2,3-oxidosqualene cyclization into lanosterol 3 9 2 by LAS (Sonawane et al., 2016) . Instead, the OSC involved is CAS, after which cycloartenol is 3 9 3 not only used for phytosterol biosynthesis, but also cholesterol biosynthesis (Fig. 2) . Indeed, in 3 9 4 tomato and potato plants it was shown that sterol side chain reductase 2 (SSR2) is a key 3 9 5 enzyme in cholesterol biosynthesis that catalyzes the conversion of cycloartenol into 3 9 6 cycloartanol, the first committed step in cholesterol biosynthesis (Sonawane et al., 2016) . Besides mutants, another way in which sterol biosynthesis can be disrupted is through 4 0 9 the action of chemical inhibitors that target specific steps of the sterol biosynthesis pathway 4 1 0 ( Fig. 2, Fig. 3 ). Indeed, sterol biosynthesis inhibitors have proven to be effective tools to probe 4 1 1 and investigate sterol biosynthesis pathways across the different kingdoms. Many of the 4 1 2 currently used sterol biosynthesis inhibitors have seen commercial use as fungicides and 4 1 3 antimycotic drugs, and some can even be used to regulate plant growth (Lenton, 1987; Leroux 4 1 4 et al., 2008) . Since the sterol biosynthesis pathways of plants, animals and yeast share many 4 1 5 similar conversion steps that are catalyzed by semi-conserved enzymes, several of the most 4 1 6 used sterol biosynthesis inhibitors function across kingdoms (Ator et al., 1992) . Nevertheless, 4 1 7 there still exist clear differences in the sterol biosynthesis pathways between the kingdoms, 4 1 8 leading to different sensitivities and specificities of sterol biosynthesis inhibitors (Nes, 2011). 4 1 9
The following paragraphs will go into more detail about some of the most active and most used 4 2 0 sterol biosynthesis inhibitors in plants, and their presumed targets. The compounds discussed 4 2 1 and their presumed targets in Arabidopsis are indicated in Fig. 2 . The numbers in brackets 4 2 2 behind the discussed compounds correlate to their numbers in Fig. 3 Kim et al., 2014; Soto et al., 2011) , demonstrating that statins can also be used as HMGR 4 2 9 inhibitors in plant sterol research. 4 3 0 2 1 Two allylamine fungicides, namely naftifine (3) and terbinafine (4), are potent non-4 3 1 competitive SQE inhibitors in fungi (Birnbaum, 1990; Ryder, 1991; Nowosielski et al., 2011) . 4 3 2 Docking analyses on modelled SQE suggest that terbinafine binding causes a conformational 4 3 3 change that blocks one mode of substrate binding, while changing the geometry of another. 4 3 4 (Nowosielski et al., 2011) . Although plant SQEs can complement yeast SQE deficient mutants 4 3 5 (Rasbery et al., 2007) , they are not highly sensitive to these inhibitors (Yates et al., 1991 (Yates et al., , 1992  Over the years, several compounds have been identified that inhibit OSCs to varying 4 5 0 degrees by mimicking the carbocationic intermediates formed during the cyclization of 2,3-4 5 1 oxidosqualene. Some examples of OSC inhibitors that have been successfully utilized in plants 4 5 2 are 2-aza-2,3-dihydrosqualene (5) (Duriatti et al., 1985; Cattel et al., 1986) , U18666A (6) 4 5 3 (Duriatti et al., 1985; Cattel et al., 1986) and AMO-1618 (7) (Douglas and Paleg, 1978 , 1978 , 4 5 4 1981 . Another class of OSC inhibitors are the 8-azadecalins, such as 4,4,10β-trimethyl-trans-4 5 5 2 2 decal-3β-ol (TMD) (8) and its derivatives (Ruhl et al., 1989; Raveendranath et al., 1990; 4 5 6 Hoshino et al., 1995) . However, the 8-azadecalins also inhibit other enzymes besides OSCs 4 5 7 (such as cyclopropyl sterol isomerase, C-14 sterol reductase and C-8,7 sterol isomerase), thus 4 5 8 potentially leading to off-target effects. 4 5 9
In Arabidopsis, the C-24 sterol methyltransferase SMT1 catalyzes the transfer of a 4 6 0 methyl group from S-adenosyl-L-methionine to cycloartenol (Benveniste, 1986; Bouvier-Nave et 4 6 1 al., 1998; Diener et al., 2000) , leading to the formation of . These inhibitors can be broadly classified in three groups: 1) substrate analogues that 4 6 8 act as inactivators of the enzyme, 2) substrate analogues that resemble high-energy 4 6 9 intermediates, and 3) product analogues. While these compounds are generally designed in 4 7 0 fungal systems, some of them have been shown to inhibit SMT1 and SMT2/CVP1 in plants as 4 7 1 well, including the azasteroid inhibitors 25-azacycloartenol (9) (Rahier et al., 1980; Schmitt et 4 7 2 al., 1981; Rahier et al., 1986; Mangla and Nes, 2000) , 25-azalanosterol (10) (Rahier et al., 4 7 3 1984) and 24-epiiminolanosterol (11) (Tal and Nes, 1987) , which are carbocationic transition 4 7 4 state analogues of the substrates of these enzymes (Rahier et al., 1984) . 4 7 5
The 14α-methylsterol demethylase enzyme in plants (obtusifoliol 14α-demethylase) 4 7 6 catalyzes the demethylation of obtusifoliol (Lepesheva and Waterman, 2007) . This enzyme is a 4 7 7 cytochrome P450 dependent monooxygenase (CYP51G1 in Arabidopsis) (Benveniste, 1986; 4 7 8 Lepesheva and Waterman, 2007) . In fungi and animals, the best studied and most widely used 4 7 9 inhibitors of P450s are the azoles, which are a popular type of antifungal compounds that are 4 8 0 2 3 used for both agricultural and medical purposes (Becher and Wirsel, 2012) . Two subclasses of 4 8 1 the azoles are the imidazoles, such as clotrimazole (12), oxiconazole (13), ketoconazole (14), 4 8 2 imazalil (enilconazole) (15) and prochloraz (16), and the triazoles, such as triadimenol (17) compounds also have an effect on plants to a varying degree, where they generally cause 4 8 8 growth inhibition, which may be due to interference with downstream BR biosynthesis 4 8 9 (Scheinpflug and Kuck, 1987; Vanden Bossche et al., 1987; Rozhon et al., 2013; Fabris et al., , that are often sensitive to imidazoles (Murray, 1999) . Of note is that azoles can be found 4 9 5 or even designed that display a certain degree of preference towards specific cytochrome P450 4 9 6 enzymes. Well-known examples in plants are uniconazole as an inhibitor of CYP707As that are 4 9 7 involved in abscisic acid catabolism (Saito et al., 2006) , and brassinazole as an inhibitor of 4 9 8 CYP90B1 that is involved in brassinosteroid biosynthesis (Asami et al., 2000) . Importantly, both 4 9 9 uniconazole and brassinazole can inhibit CYP90B1 activities, suggesting that one should be 5 0 0 wary of off-target side effects when using these inhibitors, especially when using them at high 5 0 1 concentrations. Recently, analysis of crystals of CYP90B1 in complex with uniconazole and 5 0 2 brassinazole demonstrated important differences in binding conformation (Fujiyama et al., 2019) Besides the azoles, also pyrimidine-type fungicides, such as fenarimol (20), nuarimol 5 0 6 (21) and triarimol (22), and pyridine-type fungicides are thought to affect the CYP51 ortholog 5 0 7 and other cytochrome P450 enzymes, such as CYP710A1 in plants (Shive and Sisler, 1976; 5 0 8 Schmitt and Benveniste, 1979; Buchenauer and Rohner, 1981; Burden et al., 1987; Scheinpflug 5 0 9 and Kuck, 1987; Mercer et al., 1989; Leroux et al., 2008; Oh et al., 2015) . Overall, these 5 1 0 compounds all cause strong reductions in root-and shoot growth with varying potency, and are 5 1 1 phytotoxic at high concentrations due to a severe reduction in phytosterols and an accumulation 5 1 2 of 14α-methylsterols (Burden et al., 1987; Lurssen, 1987) . 5 1 3 CPI, C-14 sterol reductase and C-8,7 sterol isomerase are enzymes that catalyze similar 5 1 4 reactions at different stages of the sterol biosynthesis pathway (Benveniste, 1986) , making them 5 1 5
shared targets for molecular inhibition. An important class of inhibitors that target these 5 1 6 enzymes are the morpholine fungicides, such as fenpropimorph (23), dodemorph (24), 5 1 7 aldimorph (25) and tridemorph (26) (Kerkenaar et al., 1981; Baloch et al., 1984;  Baloch and 5 1 8 Mercer, 1987; Mercer et al., 1989; Marcireau et al., 1990) . These compounds exert their 5 1 9 fungitoxicity by inhibiting C-8,7 sterol isomerase (nM concentrations) and/or C-14 sterol 5 2 0 reductase (µM concentration) in fungi and yeast, with different morpholines having different 5 2 1 specificities (Kerkenaar et al., 1981; Baloch et al., 1984; Baloch and Mercer, 1987; Kerkenaar, 5 2 2 1987; Marcireau et al., 1990) . For instance, while fenpropimorph can effectively inhibit both the 5 2 3 C-8,7 sterol isomerase and C-14 sterol reductase in fungi, tridemorph primarily inhibits the C-8,7 5 2 4 sterol isomerase (Baloch et al., 1984; Kerkenaar, 1987) . However, morpholines also function in 5 2 5 plants, albeit less potently and less specifically, where they have been shown to inhibit HYD1 5 2 6 (the plant C-8,7 sterol isomerase) (Rahier et al., 1986; Taton et al., 1987) , FK (the plant C-14 5 2 7 sterol reductase) (Mercer et al., 1989; Taton et al., 1989; He et al., 2003) and CPI (Taton et al., 5 2 8 1987) to a varying degree. Similarly, fenpropimorph treatment caused alterations in the sterol 5 2 9 content of the diatom P. tricornutum that could be explained by inhibition of multiple enzymes 5 3 0 2 5 involved in its sterol biosynthesis pathway (Fabris et al., 2014) . While fenpropimorph is the most 5 3 1 active and commonly used morpholine in plants, it requires relatively high concentrations to 5 3 2 function (30 -100 μ M), is unstable and relatively expensive. Plants treated with morpholines 5 3 3 have a disturbed sterol profile and growth impairments, similar to mutants defective in the 5 3 4 targeted enzymes (Bladocha and Benveniste, 1983; Burden et al., 1987; He et al., 2003) . 5 3 5
However, while the morpholine compounds disturb the normal sterol profile of plants, they are 5 3 6
generally not phytotoxic (Bladocha and Benveniste, 1983; Taton et al., 1987 Taton et al., , 1987 . 5 3 7
Interestingly, in plants, 8-azadecalins such as N-benzyl-8-aza-4α,10-dimethyl-trans-decal-3β-ol 5 3 8 (27) and N-(1,5,9-trimethyldecyl)-4α,10-dimethyl-8-aza-trans-decal-3β-ol (TMDAD) (28) have 5 3 9 been shown to be more potent inhibitors of HYD1 and CPI than the morpholines (Rahier et al., 5 4 0 1985; Taton et al., 1987) . A strong, more specific inhibitor of C-14 sterol reductases is the 5 4 1 antifungal agent 15-aza-24-methylene-D-homocholesta-8,14-dien-3β-ol (15-azasterol) (29), 5 4 2 which has been used to inhibit FK in several plant species, including Arabidopsis (Schrick et al., 5 4 3 2002) and bramble cells (Schmitt et al., 1980) .
4 4
While most of the abovementioned sterol biosynthesis inhibitors have been used to 5 4 5 inhibit plant growth and study plant and diatom sterol biosynthesis to some degree, it is clear 5 4 6 that many of these compounds originate as antifungal compounds for which the effect in plants 5 4 7 is often not completely understood. Indeed, much of the underlying mechanisms of these 5 4 8 inhibitors in plants and diatoms are still not completely clear and are often presumed based on 5 4 9 their function in fungi and/or animals. It should also be noted that only limited recent data is 5 5 0 available for most of these inhibitors in plants, as evidenced by the relatively old sources 5 5 1 referenced in the last paragraphs. This further supports the notion that the current knowledge 5 5 2 and toolset of sterol biosynthesis inhibitors in plants is lacking. The identification of more active 5 5 3 compounds that selectively target specific enzymes in the plant sterol biosynthesis pathway 5 5 4 2 6 through a systematic approach, informed by crystal structures, would therefore be highly 5 5 5 welcomed to study sterol biosynthesis in the green lineage. 5 5 6 2 7 5 5 7 C  o  n  f  l  i  c  t  s  o  f  I  n  t  e  r  e  s  t  :   T  h  e  a  u  t  h  o  r  s  d  e  c  l  a  r  e  n  o  c  o  n  f  l  i  c  t  o  f  i  n  t  e  r  e  s  t  5  6  2 
